Cargando…

Infektionen bei immunkompromittierten Patienten

Patients with immunodeficiency and/or under immunosuppressive therapy have an increased risk of complications due to infectious diseases. After solid organ transplantation infections are the second most common cause of death. Prophylactic measures should therefore routinely be carried out. Infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Guberina, H., Sava, M., Witzke, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104138/
https://www.ncbi.nlm.nih.gov/pubmed/32288845
http://dx.doi.org/10.1007/s11560-016-0098-6
_version_ 1783512181364490240
author Guberina, H.
Sava, M.
Witzke, O.
author_facet Guberina, H.
Sava, M.
Witzke, O.
author_sort Guberina, H.
collection PubMed
description Patients with immunodeficiency and/or under immunosuppressive therapy have an increased risk of complications due to infectious diseases. After solid organ transplantation infections are the second most common cause of death. Prophylactic measures should therefore routinely be carried out. Infections in immunosuppressed patients may be associated with atypical clinical symptoms making the diagnosis and therapy a challenge for the treating physician. Viral and opportunistic infections in particular can be a therapeutic pitfall. A careful surveillance of the patient with respect to infectious diseases is essential in order to be able to make an early diagnosis and initiate appropriate measures.
format Online
Article
Text
id pubmed-7104138
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-71041382020-03-31 Infektionen bei immunkompromittierten Patienten Guberina, H. Sava, M. Witzke, O. Nephrologe Leitthema Patients with immunodeficiency and/or under immunosuppressive therapy have an increased risk of complications due to infectious diseases. After solid organ transplantation infections are the second most common cause of death. Prophylactic measures should therefore routinely be carried out. Infections in immunosuppressed patients may be associated with atypical clinical symptoms making the diagnosis and therapy a challenge for the treating physician. Viral and opportunistic infections in particular can be a therapeutic pitfall. A careful surveillance of the patient with respect to infectious diseases is essential in order to be able to make an early diagnosis and initiate appropriate measures. Springer Medizin 2016-10-28 2016 /pmc/articles/PMC7104138/ /pubmed/32288845 http://dx.doi.org/10.1007/s11560-016-0098-6 Text en © Springer-Verlag Berlin Heidelberg 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitthema
Guberina, H.
Sava, M.
Witzke, O.
Infektionen bei immunkompromittierten Patienten
title Infektionen bei immunkompromittierten Patienten
title_full Infektionen bei immunkompromittierten Patienten
title_fullStr Infektionen bei immunkompromittierten Patienten
title_full_unstemmed Infektionen bei immunkompromittierten Patienten
title_short Infektionen bei immunkompromittierten Patienten
title_sort infektionen bei immunkompromittierten patienten
topic Leitthema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104138/
https://www.ncbi.nlm.nih.gov/pubmed/32288845
http://dx.doi.org/10.1007/s11560-016-0098-6
work_keys_str_mv AT guberinah infektionenbeiimmunkompromittiertenpatienten
AT savam infektionenbeiimmunkompromittiertenpatienten
AT witzkeo infektionenbeiimmunkompromittiertenpatienten